This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Precision for Medicine Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kati Bourquain: Patents in Epigenetic Cell Identification.
Introduction
Kati Bourquain is an inventor associated with Berlin, Germany, and Precision for Medicine GmbH. Her patent work focuses on epigenetic markers that may help identify specific cell types.
Latest Patents
Bourquain’s listed patents include “MYH11/NDE1 Region as Epigenetic Marker for the Identification of Endothelial Progenitor Cells (EPCs)” and “CBX6 as Epigenetic Marker for the Identification of Immune Cells, in Particular Memory B Cells.” These inventions concern the use of epigenetic markers to distinguish endothelial progenitor cells and immune cells, including memory B cells. She is credited with 2 patents.
Career Highlights
Bourquain’s listed work connects her with Precision for Medicine GmbH and research into epigenetic approaches to cell identification. The available information does not specify her role or provide further details about her career.
Collaborations
Her listed coworkers include Sven Olek and Udo Baron. The available information does not describe the nature of their collaborations.
Conclusion
Kati Bourquain’s two listed patents focus on epigenetic markers for identifying endothelial progenitor cells and immune cells, reflecting a specialized contribution to cell-identification research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile